Want to join the conversation?
Drug and medical device maker $BAX reported jump in 4Q15 earnings from continuing operations as post-spin margin expansion efforts gain momentum and contribute to strong performance. Income rose to $190MM or $0.34 per share from $127MM or $0.23 per share last year. Sales slid 7% to $2.6Bil. Adjusted EPS grew to $0.43 from $0.28.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?